TGFB1 and colorectal carcinoma: To further validate the effects of TGFβ-blockade on human CAF dynamics, we tested TGFβ-neutralizing antibodies on freshly dissociated samples of human microsatellite-stable colorectal carcinomas (MSS-CRC), a desmoplastic tumor type that is poorly responsive to immunotherapy.